SCHEMBL21756949

SCHEMBL21756949

CC(C)c1c(O)cc(I)cc1F

nearest known ligand 0.43

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 2/20 0.43
GABRB2 P47870 2/20 0.43
GABRB1 P18505 1/20 0.43
TTR P02766 1/20 0.36
AHR P35869 1/20 0.35
BCL2 P10415 1/20 0.34
BCL2L1 Q07817 1/20 0.34
MCL1 Q07820 1/20 0.34
BCL2L2 Q92843 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21756924 0.84 GABRA1 (0.41) GABRA1GABRB2GABRB1TTR
SCHEMBL17402434 0.78 AHR (0.37) GABRA1GABRB2AHRBCL2BCL2L1
SCHEMBL19695773 0.78 CA9 (0.39) GABRA1GABRB2AHRBCL2BCL2L1
SCHEMBL21765276 0.77 GABRA1 (0.35) GABRA1GABRB2GABRB1
SCHEMBL21756930 0.77 GABRA1 (0.35) GABRA1GABRB2GABRB1BCL2BCL2L1
SCHEMBL24248982 0.77 SELL (0.48) GABRA1GABRB2AHRBCL2BCL2L1
SCHEMBL1349867 0.76 GABRA1 (0.38) GABRA1GABRB2GABRB1TTR
SCHEMBL27033289 0.75 GABRA1 (0.43) GABRA1GABRB2GABRB1AHRBCL2
SCHEMBL21765277 0.75 GABRA1 (0.34) GABRA1GABRB2GABRB1
SCHEMBL21769673 0.75 GABRA1 (0.34) GABRA1GABRB2GABRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020039088-A2 NOVEL COMPOUNDS Xeniopro GmbH (DE) 2020-02-27 WO disclosed
WO-2020039092-A2 NOVEL AROMATIC MOLECULES Xeniopro GmbH (DE) 2020-02-27 WO disclosed
WO-2020039094-A1 PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERATIVE ACTIVITY Xeniopro GmbH (DE) 2020-02-27 WO disclosed
US-9403829-B2 Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1H)-one, a solid form thereof and methods of their use SIGNAL PHARMACEUTICALS, LLC (US) 2016-08-02 US disclosed